Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Fuentes, Eduardo ^a,b   Fuentes, Francisco ^c   Vilahur, Gemma ^d   Badimon, Lina ^d   Palomo, Iván ^a,b  

^a UNIVERSIDAD DE TALCA   (Chile)

^b Centro de Estudios en Alimentos Procesados (CEAP)   (Chile)

^c UNIVERSIDAD CATÓLICA DEL MAULE   (Chile)

^d Institut Català de Ciències Cardiovasculars   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMYLOID A PROTEIN; CCAAT ENHANCER BINDING PROTEIN; HAPTOGLOBIN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT;

ABDOMINAL OBESITY; ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DNA MODIFICATION; DYSLIPIDEMIA; GENE EXPRESSION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LEUKOCYTE; LIFESTYLE MODIFICATION; LIPID DIET; LIPID METABOLISM; LYMPHOCYTIC INFILTRATION; MACROPHAGE; METABOLIC SYNDROME X; MONOCYTE; NATURAL KILLER T CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SEDENTARY LIFESTYLE; SIGNAL TRANSDUCTION; THROMBOSIS; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; LYMPHOCYTE; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; REVIEW; COMPLICATION;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LEUKOCYTES; LYMPHOCYTES; MACROPHAGES; METABOLIC SYNDROME X; MICE; OBESITY;

EID: 84880170246     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/136584     Document Type: Article

References (158)

1. Lakka H.-M., Laaksonen D. E., Lakka T. A., Niskanen L. K., Kumpusalo E., Tuomilehto J., Salonen J. T., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 2002 288 21 2709 2716 2-s2.0-0037021505 10.1001/jama.288.21. 2709 (Pubitemid 35403784)
2. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D. S. J., Haffner S. M., Isles C., Macfarlane P. W., Packard C. J., Cobbe S. M., Shepherd J., Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003 108 4 414 419 2-s2.0-0042665536 10.1161/01.CIR. 0000080897.52664.94 (Pubitemid 36935533)
3. Palomo I., Moore-Carrasco R., Alarcon M., Rojas A., Espana F., Andres V., Gonzalez-Navarro H., Pathophysiology of the proatherothrombotic state in the metabolic syndrome. Frontiers in Bioscience 2010 2 194 208 2-s2.0-77957313606
4. Palomo I., Toro C., Alarcón M., The role of platelets in the pathophysiology of atherosclerosis (review). Molecular Medicine Reports 2008 1 2 179 184 2-s2.0-69249156463
5. Aledo R., Alonso R., Mata P., Llorente-Cortés V., Padro T., Badimon L., LRP1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia. Revista Española de Cardiología 2012 65 807 812
6. Vera R. H., Vilahur G., Ferrer-Lorente R., Pena E., Badimon L., Platelets derived from the bone marrow of diabetic animals show dysregulated endoplasmic reticulum stress proteins that contribute to increased thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 2141 2148
7. Vera R. H., Vilahur G., Badimon L., Obesity with insulin resistance increase thrombosis in wild-type and bone marrow-transplanted Zucker fatty rats. Thrombosis and Haemostasis 2012 109 319 327 10.1160/TH12-09-0696
8. Gasparyan A. Y., Ayvazyan L., Mikhailidis D. P., Kitas G. D., Mean platelet volume: a link between thrombosis and inflammation? Current Pharmaceutical Design 2011 17 1 47 58 2-s2.0-79953738262 10.2174/ 138161211795049804
9. Shoelson S. E., Goldfine A. B., Getting away from glucose: fanning the flames of obesity-induced inflammation. Nature Medicine 2009 15 4 373 374 2-s2.0-64149101055 10.1038/nm0409-373
10. Badimon L., Storey R. F., Vilahur G., Update on lipids, inflammation and atherothrombosis. Thrombosis and Haemostasis 2011 105 supplement 1 S34 S42 2-s2.0-79960986843 10.1160/THS10-11-0717
11. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor-: direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 (Pubitemid 23036092)
12. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
13. Orio F. Jr., Palomba S., Cascella T., Savastano S., Lombardi G., Colao A., Cardiovascular complications of obesity in adolescents. Journal of Endocrinological Investigation 2007 30 1 70 80 2-s2.0-33947512931 (Pubitemid 46470387)
14. Grundy S. M., Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2595 2600 2-s2.0-2942675088 10.1210/jc.2004-0372 (Pubitemid 38766337)
15. Steiner G., Cahill G. F. Jr., Adipose tissue physiology. Annals of the New York Academy of Sciences 1963 110 749 753 2-s2.0-75449124293
16. Hajer G. R., Van Haeften T. W., Visseren F. L. J., Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 2008 29 24 2959 2971 2-s2.0-58049219012 10.1093/eurheartj/ehn387
17. Fraser J. K., Wulur I., Alfonso Z., Hedrick M. H., Fat tissue: an underappreciated source of stem cells for biotechnology. Trends in Biotechnology 2006 24 4 150 154 2-s2.0-33646103658 10.1016/j.tibtech.2006.01.010
18. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 2-s2.0-2942650969 10.1210/jc.2004-0395 (Pubitemid 38766330)
19. Nishimura S., Manabe I., Nagai R., Adipose tissue inflammation in obesity and metabolic syndrome. Discovery medicine 2009 8 41 55 60 2-s2.0-77249132284
20. Bastard J. P., Maachi M., Lagathu C., Kim M. J., Caron M., Vidal H., Capeau J., Feve B., Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network 2006 17 1 4 12 2-s2.0-33745896155
21. Iizuka K., Horikawa Y., ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocrine Journal 2008 55 4 617 624 2-s2.0-51449106076 10.1507/endocrj.K07E-110
22. Pérez P. M., Moore-Carrasco R., González D. R., Fuentes E. Q., Palomo I. G., Gene expression of adipose tissue, endothelial cells and platelets in subjects with metabolic syndrome (review). Molecular Medicine Reports 2012 5 5 1135 1140 2-s2.0-84858212581 10.3892/mmr.2012.785
23. Salmenniemi U., Ruotsalainen E., Pihlajamäki J., Vauhkonen I., Kainulainen S., Punnonen K., Vanninen E., Laakso M., Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004 110 25 3842 3848 2-s2.0-11144346107 10.1161/01.CIR.0000150391. 38660.9B (Pubitemid 40023983)
24. Mujica V., Leiva E., Icaza G., Diaz N., Arredondo M., Moore-Carrasco R., Orrego R., Vásquez M., Palomo I., Evaluation of metabolic syndrome in adults of Talca city, Chile. Nutrition Journal 2008 7 1, article 14 2-s2.0-44349098089 10.1186/1475-2891-7-14 (Pubitemid 351749374)
25. Palomo I., Contreras A., Alarcón L. M., Leiva E., Guzmán L., Mujica V., Icaza G., Díaz N., González D. R., Moore-Carrasco R., Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome. Nitric Oxide 2011 24 4 224 228 2-s2.0-79956371796 10.1016/j.niox.2011.03.002
26. Palomo I., Alarcón M., Moore-Carrasco R., Argilés J. M., Hemostasis alterations in metabolic syndrome (review). International Journal of Molecular Medicine 2006 18 5 969 974 2-s2.0-37349053532
27. Palomo I. G., Jaramillo J. C., Alarcón M. L., Gutiérrez C. L., Moore-Carrasco R., Segovia F. M., Leiva E. M., Mujica V. E., Icaza G., Díaz N. S., Increased concentrations of soluble vascular cell adhesion molecule-1 and soluble CD40L in subjects with metabolic syndrome. Molecular Medicine Reports 2009 2 3 481 485 2-s2.0-69249154695 10.3892/mmr-00000125
28. Gómez J. M., Vila R., Catalina P., Soler J., Badimón L., Sahún M., The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives. Glycoconjugate Journal 2008 25 6 573 579 2-s2.0-46649092931 10.1007/s10719-008-9118-8
29. Palomo I. G., Gutiérrez C. L., Alarcón M. L., Jaramillo J. C., Segovia F. M., Leiva E. M., Mujica V. E., Icaza G. N., Díaz N. S., Moore-Carrasco R., Increased concentration of plasminogen activator inhibitor-1 and fibrinogen in individuals with metabolic syndrome. Molecular Medicine Reports 2009 2 2 253 257 2-s2.0-69249132924 10.3892/mmr-00000092
30. Krupinski J., Turu M. M., Font M. A., Ahmed N., Sullivan M., Luque A., Rubio F., Badimon L., Slevin M., Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis. Vascular Health and Risk Management 2007 3 4 405 412 2-s2.0-35148896833 (Pubitemid 47542602)
31. Salmenniemi U., Ruotsalainen E., Vänttinen M., Vauhkonen I., Pihlajamäki J., Kainulainen S., Punnonen K., Laakso M., High amount of visceral fat mass is associated with multiple metabolic changes in offspring of type 2 diabetic patients. International Journal of Obesity 2005 29 12 1464 1470 2-s2.0-27744581463 10.1038/sj.ijo.0803041 (Pubitemid 41622226)
32. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I., Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal of Clinical Investigation 2004 114 12 1752 1761 2-s2.0-15244342531 10.1172/JCI200421625 (Pubitemid 40385531)
33. Satoh M., Andoh Y., Clingan C. S., Ogura H., Fujii S., Eshima K., Nakayama T., Taniguchi M., Hirata N., Ishimori N., Tsutsui H., Onoé K., Iwabuchi K., Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS One 2012 7 2 2-s2.0-84857470273 10.1371/journal.pone.0030568 e30568
34. Madsen E. L., Rissanen A., Bruun J. M., Skogstrand K., Tonstad S., Hougaard D. M., Richelsen B., Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. European Journal of Endocrinology 2008 158 2 179 187 2-s2.0-38949205723 10.1530/EJE-07-0721 (Pubitemid 351298534)
35. Zoico E., Rossi A., Di Francesco V., Sepe A., Olioso D., Pizzini F., Fantin F., Bosello O., Cominacini L., Harris T. B., Zamboni M., Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level. Journals of Gerontology A 2010 65 3 295 299 2-s2.0-77949524652 10.1093/gerona/glp155
36. Barreda R., Ros P. R., Diagnostic imaging of liver abscess. Critical Reviews in Diagnostic Imaging 1991 33 1-2 29 58 2-s2.0-0026068387
37. Pittas A. G., Joseph N. A., Greenberg A. S., Adipocytokines and insulin resistance. Journal of Clinical Endocrinology and Metabolism 2004 89 2 447 452 2-s2.0-1442327902 10.1210/jc.2003-031005 (Pubitemid 38269842)
38. Omran S. A., Amer A. M., el-Kaliouby A. H., Eldin A. A., Study of contact activation in endemic hepatosplenomegaly. Blood Coagulation & Fibrinolysis 1991 2 5 659 662 2-s2.0-0026235513
39. Ryan A. S., Berman D. M., Nicklas B. J., Sinha M., Gingerich R. L., Meneilly G. S., Egan J. M., Elahi D., Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003 26 8 2383 2388 2-s2.0-0042023742 10.2337/diacare.26.8.2383 (Pubitemid 36993330)
40. Matsubara M., Maruoka S., Katayose S., Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. European Journal of Endocrinology 2002 147 2 173 180 2-s2.0-0036678916
41. Flier J. S., Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004 116 2 337 350 2-s2.0-0842324779 10.1016/S0092-8674(03)01081- X (Pubitemid 38167322)
42. Onate B., Vilahur G., Ferrer-Lorente R., Ybarra J., Díez-Caballero A., Ballesta-López C., Moscatiello F., Herrero J., Badimon L., The subcutaneous adipose tissue reservoir of functionally active stem cells is reduced in obese patients. FASEB J 2012 26 4327 4336
43. Ahima R. S., Adipose tissue as an endocrine organ. Obesity 2006 14 supplement 5 242S 249S 2-s2.0-34247556686 10.1038/oby.2006.317
44. Lumeng C. N., Saltiel A. R., Inflammatory links between obesity and metabolic disease. Journal of Clinical Investigation 2011 121 6 2111 2117 2-s2.0-79957920754 10.1172/JCI57132
45. Trayhurn P., Wood I. S., Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004 92 3 347 355 2-s2.0-6944237757 10.1079/BJN20041213 (Pubitemid 40277057)
46. Badimon L., Romero J. C., Cubedo J., Borrell-Pages M., Circulating biomarkers. Thrombosis Research 2012 130 supplement 1 S12 S15
47. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003 112 12 1821 1830 2-s2.0-9144223683 10.1172/JCI200319451 (Pubitemid 38063705)
48. Kern P. A., Ranganathan S., Li C., Wood L., Ranganathan G., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American Journal of Physiology 2001 280 5 E745 E751 2-s2.0-0035023128
49. Shimomura I., Funahashi T., Takahashi M., Maeda K., Kotani K., Nakamura T., Yamashita S., Miura M., Fukuda Y., Takemura K., Tokunaga K., Matsuzawa Y., Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Medicine 1996 2 7 800 803 2-s2.0-15844381594 10.1038/nm0796-800 (Pubitemid 26225097)
50. Engeli S., Feldpausch M., Gorzelniak K., Hartwig F., Heintze U., Janke J., Möhlig M., Pfeiffer A. F. H., Luft F. C., Sharma A. M., Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003 52 4 942 947 2-s2.0-0037380664 10.2337/diabetes.52.4.942 (Pubitemid 36384264)
51. Krakoff J., Funahashi T., Stehouwer C. D. A., Schalkwijk C. G., Tanaka S., Matsuzawa Y., Kobes S., Tataranni P. A., Hanson R. L., Knowler W. C., Lindsay R. S., Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003 26 6 1745 1751 2-s2.0-10744231067 10.2337/diacare.26.6.1745 (Pubitemid 36929114)
52. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., Okamoto Y., Ohashi K., Nagaretani H., Kishida K., Nishizawa H., Maeda N., Kobayashi H., Hiraoka H., Matsuzawa Y., Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003 107 5 671 674 2-s2.0-0037432152 10.1161/01.CIR.0000055188.83694.B3 (Pubitemid 36222590)
53. Turu M. M., Slevin M., Matou S., West D., Rodríguez C., Luque A., Grau-Olivares M., Badimon L., Martinez-Gonzalez J., Krupinski J., C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression. BMC Cell Biology 2008 9, article 47 2-s2.0-52949112332 10.1186/1471-2121-9-47
54. Nasarre L., Juan-Babot O., Gastelurrutia P., Llucia-Valldeperas A., Badimon L., Bayes-Genis A., Llorente-Cortés V., Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels. Acta Diabetologica 2012 10.1007/s00592-012-0436-8
55. Chakrabarti S. K., Cole B. K., Wen Y., Keller S. R., Nadler J. L., 12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3t3-l1 adipocytes. Obesity 2009 17 9 1657 1663 2-s2.0-69749102190 10.1038/oby.2009.192
56. Dobrian A. D., Lieb D. C., Ma Q., Lindsay J. W., Cole B. K., Ma K., Chakrabarti S. K., Kuhn N. S., Wohlgemuth S. D., Fontana M., Nadler J. L., Differential expression and localization of 12/15 lipoxygenases in adipose tissue in human obese subjects. Biochemical and Biophysical Research Communications 2010 403 3-4 485 490 2-s2.0-78650173914 10.1016/j.bbrc.2010.11. 065
57. Bruce C. R., Dyck D. J., Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor- American Journal of Physiology 2004 287 4 E616 E621 2-s2.0-4544259980 10.1152/ajpendo.00150.2004 (Pubitemid 39237888)
58. Dyck D. J., Adipokines as regulators of muscle metabolism and insulin sensitivity. Applied Physiology, Nutrition and Metabolism 2009 34 3 396 402 2-s2.0-67651216391 10.1139/H09-037
59. Rydén M., Dicker A., Van Harmelen V., Hauner H., Brunnberg M., Perbeck L., Lönnqvist F., Arner P., Mapping of early signaling events in tumor necrosis factor- -mediated lipolysis in human fat cells. Journal of Biological Chemistry 2002 277 2 1085 1091 2-s2.0-0037059777 10.1074/jbc. M109498200 (Pubitemid 34968854)
60. Kaidashev I. P., NF-kB activation as a molecular basis of pathological process by metabolic syndrome. Fiziolohichnyi Zhurnal 2012 58 93 101
61. Ye J., Gao Z., Yin J., He Q., Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. American Journal of Physiology 2007 293 4 E1118 E1128 2-s2.0-35148854599 10.1152/ajpendo.00435.2007 (Pubitemid 47535846)
62. Araki K., Kawauchi K., Tanaka N., IKK/NF- B signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors. Oncogene 2008 27 43 5696 5705 2-s2.0-52949090392 10.1038/onc.2008.184
63. Ahn J., Lee H., Kim S., Ha T., Resveratrol inhibits TNF- -induced changes of adipokines in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2007 364 4 972 977 2-s2.0-36048974865 10.1016/j.bbrc.2007.10.109 (Pubitemid 350090002)
64. Hotamisligil G. S., Arner P., Caro J. F., Atkinson R. L., Spiegelman B. M., Increased adipose tissue expression of tumor necrosis factor- in human obesity and insulin resistance. Journal of Clinical Investigation 1995 95 5 2409 2415 2-s2.0-0028931724
65. Gómez R., Conde J., Scotece M., Gómez-Reino J. J., Lago F., Gualillo O., What's new in our understanding of the role of adipokines in rheumatic diseases? Nature Reviews Rheumatology 2011 7 9 528 536 2-s2.0-80052409973 10.1038/nrrheum.2011.107
66. Lago F., Dieguez C., Gómez-Reino J., Gualillo O., Adipokines as emerging mediators of immune response and inflammation. Nature Clinical Practice Rheumatology 2007 3 12 716 724 2-s2.0-36549042103 10.1038/ncprheum0674 (Pubitemid 350187017)
67. Lago F., Gómez R., Gómez-Reino J. J., Dieguez C., Gualillo O., Adipokines as novel modulators of lipid metabolism. Trends in Biochemical Sciences 2009 34 10 500 510 2-s2.0-70349314629 10.1016/j.tibs.2009.06.008
68. Ferraz-Amaro I., Gonzalez-Juanatey C., Lopez-Mejias R., Riancho-Zarrabeitia L., Gonzalez-Gay M. A., Metabolic syndrome in rheumatoid arthritis. Mediators of Inflammation 2013 2013 7 710928 10.1155/2013/710928
69. Gonzalez-Gay M. A., Llorca J., Garcia-Unzueta M. T., Gonzalez-Juanatey C., De Matias J. M., Martin J., Redelinghuys M., Woodiwiss A. J., Norton G. R., Dessein P. H., High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. Clinical and Experimental Rheumatology 2008 26 4 596 603 2-s2.0-52649173297
70. Gonzalez-Gay M. A., Garcia-Unzueta M. T., Berja A., Gonzalez-Juanatey C., Miranda-Filloy J. A., Vazquez-Rodriguez T. R., Matias J. M. D., Martin J., Dessein P. H., Llorca J., Anti-TNF- therapy does not modulate leptin in patients with severe rheumatoid arthritis. Clinical and Experimental Rheumatology 2009 27 2 222 228 2-s2.0-67249123828
71. Conde J., Scotece M., Lopez V., Gomez R., Lago F., Pino J., Gómez-Reino J. J., Gualillo O., Adiponectin and leptin induce VCAM-1 expression in human and murine chondrocytes. PLoS One 2012 7 e52533
72. Gonzalez-Juanatey C., Llorca J., Sanchez Andrade A., Garcia-Porrua C., Martin J., Gonzalez-Gay M. A., Short-term adalimumab therapy improves endothelial function in patients with rheumatoid arthritis refractory to infliximab. Clinical and Experimental Rheumatology 2006 24 3 309 312 2-s2.0-33744792493 (Pubitemid 44151152)
73. Gonzales-Gay M. A., Garcia-Unzueta M. T., De Matias J. M., Gonzalez-Juanatey C., Garcia-Porrua C., Sanchez-Andrade A., Martin J., Ilorca J., Influence of anti-TNF- infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 2006 24 4 373 379 2-s2.0-33748519856 (Pubitemid 44363537)
74. Gonzalez-Gay M. A., Garcia-Unzueta M. T., Gonzalez-Juanatey C., Miranda-Filloy J. A., Vazquez-Rodriguez T. R., de Matias J. M., Martin J., Dessein P. H., Llorca J., Anti-TNF- therapy modulates resistin in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 2008 26 2 311 316 2-s2.0-43349098447 (Pubitemid 351659139)
75. Heilbronn L. K., Campbell L. V., Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Current Pharmaceutical Design 2008 14 12 1225 1230 2-s2.0-47149096915 10.2174/138161208784246153 (Pubitemid 351997835)
76. Badimon L., Interleukin-18: a potent pro-inflammatory cytokine in atherosclerosis. Cardiovascular Research 2012 96 172 175
77. Fain J. N., Madan A. K., Hiler M. L., Cheema P., Bahouth S. W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004 145 5 2273 2282 2-s2.0-2042480671 10.1210/en.2003-1336 (Pubitemid 38535056)
78. Cinti S., Mitchell G., Barbatelli G., Murano I., Ceresi E., Faloia E., Wang S., Fortier M., Greenberg A. S., Obin M. S., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research 2005 46 11 2347 2355 2-s2.0-27444437321 10.1194/jlr.M500294-JLR200 (Pubitemid 41532523)
79. + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nature Medicine 2009 15 8 914 920 2-s2.0-68349150756 10.1038/nm.1964
80. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., Fischer-Posovszky P., Barth T. F. E., Dragun D., Skurk T., Hauner H., Blüher M., Unger T., Wolf A.-M., Knippschild U., Hombach V., Marx N., T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1304 1310 2-s2.0-46249117032 10.1161/ATVBAHA.108.165100
81. Rausch M. E., Weisberg S., Vardhana P., Tortoriello D. V., Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. International Journal of Obesity 2008 32 3 451 463 2-s2.0-38149142633 10.1038/sj.ijo.0803744 (Pubitemid 351414814)
82. Ohmura K., Ishimori N., Ohmura Y., Tokuhara S., Nozawa A., Horii S., Andoh Y., Fujii S., Iwabuchi K., Onoé K., Tsutsui H., Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 2 193 199 2-s2.0-75149169811 10.1161/ATVBAHA.109.198614
83. + T-Cells are not protected against the metabolic abnormalities of diet-induced obesity. PLoS One 2011 6 6 2-s2.0-79958022995 10.1371/journal. pone.0019831 e19831
84. Villalta S. A., Nguyen H. X., Deng B., Gotoh T., Tidbal J. G., Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Human Molecular Genetics 2009 18 3 482 496 2-s2.0-58749098598 10.1093/hmg/ddn376
85. Ishii M., Wen H., Corsa C. A. S., Liu T., Coelho A. L., Allen R. M., Carson W. F. IV, Cavassani K. A., Li X., Lukacs N. W., Hogaboam C. M., Dou Y., Kunkel S. L., Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 2009 114 15 3244 3254 2-s2.0-70350435962 10.1182/blood-2009-04- 217620
86. Bouloumié A., Curat C. A., Sengenès C., Lolmède K., Miranville A., Busse R., Role of macrophage tissue infiltration in metabolic diseases. Current Opinion in Clinical Nutrition & Metabolic Care 2005 8 347 354 (Pubitemid 40863045)
87. Lumeng C. N., Bodzin J. L., Saltiel A. R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation 2007 117 1 175 184 2-s2.0-33846026712 10.1172/JCI29881 (Pubitemid 46048464)
88. Lumeng C. N., Delproposto J. B., Westcott D. J., Saltiel A. R., Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008 57 12 3239 3246 2-s2.0-58149347227 10.2337/db08-0872
89. Salmenniemi U., Zacharova J., Ruotsalainen E., Vauhkonen I., Pihlajamäki J., Kainulainen S., Punnonen K., Laakso M., Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients. Journal of Clinical Endocrinology and Metabolism 2005 90 7 4216 4223 2-s2.0-23044507939 10.1210/jc.2004-2289 (Pubitemid 41058200)
90. Cnop M., Havel P. J., Utzschneider K. M., Carr D. B., Sinha M. K., Boyko E. J., Retzlaff B. M., Knopp R. H., Brunzell J. D., Kahn S. E., Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003 46 4 459 469 2-s2.0-0038293399 (Pubitemid 36577787)
91. Kim O. Y., Koh S. J., Jang Y., Chae J. S., Kim J. Y., Kim H. J., Cho H., Lee J. H., Plasma adiponectin is related to other cardiovascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: cross-sectional analysis. Clinica Chimica Acta 2006 370 1-2 63 71 2-s2.0-33746220437 10.1016/j.cca.2006.01.021 (Pubitemid 44096944)
92. Sans S., Padro T., Tuomilehto J., Badimon L., Incidence of diabetes and serum adipokines in Catalonian men. The ADIPOCAT study. Annals of Medicine 2012 45 1 97 102 10.3109/07853890.2012.679958
93. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y., Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999 100 25 2473 2476 2-s2.0-0033613545 (Pubitemid 30005109)
94. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., Arita Y., Okamoto Y., Shimomura I., Hiraoka H., Nakamura T., Funahashi T., Matsuzawa Y., Association of hypoadiponectinemia with coronary artery disease in men. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 1 85 89 2-s2.0-0037231459 10.1161/01.ATV.0000048856.22331.50 (Pubitemid 36091630)
95. Ohashi K., Parker J. L., Ouchi N., Higuchi A., Vita J. A., Gokce N., Pedersen A. A., Kalthoff C., Tullin S., Sams A., Summer R., Walsh K., Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. Journal of Biological Chemistry 2010 285 9 6153 6160 2-s2.0-77949881805 10.1074/jbc.M109.088708
96. Lovren F., Pan Y., Quan A., Szmitko P. E., Singh K. K., Shukla P. C., Gupta M., Chan L., Al-Omran M., Teoh H., Verma S., Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. American Journal of Physiology 2010 299 3 H656 H663 2-s2.0-77956679336 10.1152/ajpheart.00115.2010
97. Mandal P., Park P.-H., McMullen M. R., Pratt B. T., Nagy L. E., The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat kupffer cells. Hepatology 2010 51 4 1420 1429 2-s2.0-77950625277 10.1002/hep.23427
98. Mandal P., Pratt B. T., Barnes M., McMullen M. R., Nagy L. E., Molecular mechanism for adiponectin-dependent m2 macrophage polarization link between the metabolic and innate immune activity of full-length adiponectin. Journal of Biological Chemistry 2011 286 15 13460 13469 2-s2.0-79953863868 10.1074/jbc.M110.204644
99. Hara K., Horikoshi M., Kitazato H., Yamauchi T., Ito C., Noda M., Ohashi J., Froguel P., Tokunaga K., Nagai R., Kadowaki T., Absence of an association between the polymorphisms in the genes encoding adiponectin receptors and type 2 diabetes. Diabetologia 2005 48 7 1307 1314 2-s2.0-23944519102 10.1007/s00125-005-1806-3 (Pubitemid 41186095)
100. Collins S. C., Luan J., Thompson A. J., Daly A., Semple R. K., O'Rahilly S., Wareham N. J., Barroso I., Adiponectin receptor genes: mutation screening in syndromes of insulin resistance and association studies for type 2 diabetes and metabolic traits in UK populations. Diabetologia 2007 50 3 555 562 2-s2.0-33846784881 10.1007/s00125-006-0534-7 (Pubitemid 46215498)
101. Khan R. S., Kato T. S., Chokshi A., Chew M., Yu S., Wu C., Singh P., Cheema F. H., Takayama H., Harris C., Reyes-Soffer G., Knöll R., Milting H., Naka Y., Mancini D., Schulze P. C., Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation. Circulation 2012 5 340 348
102. Aprahamian T., Bonegio R. G., Richez C., Yasuda K., Chiang L.-K., Sato K., Walsh K., Rifkin I. R., The peroxisome proliferator-activated receptor γ agonist rosiglitazone ameliorates murine lupus by induction of adiponectin. Journal of Immunology 2009 182 1 340 346 2-s2.0-59849087383
103. Choi H.-M., Lee Y.-A., Lee S.-H., Hong S.-J., Hahm D.-H., Choi S.-Y., Yang H.-I., Yoo M. C., Kim K. S., Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators. Arthritis Research and Therapy 2009 11 6, article no. R161 2-s2.0-77952490138 10.1186/ar2844
104. Lindström T., Frystyk J., Hedman C. A., Flyvbjerg A., Arnqvist H. J., Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration. Clinical Endocrinology 2006 65 6 776 782 2-s2.0-33751108249 10.1111/j.1365-2265.2006.02666.x (Pubitemid 44772359)
105. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Adiponectin and adiponectin receptors in obesity-linked insulin resistance. Novartis Foundation Symposium 2007 286 164 176 2-s2.0-42449119389
106. You T., Yang R., Lyles M. F., Gong D., Nicklas B. J., Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. American Journal of Physiology 2005 288 4 E741 E747 2-s2.0-15444377785 10.1152/ajpendo.00419.2004 (Pubitemid 40397209)
107. Keaney J. F. Jr., Larson M. G., Vasan R. S., Wilson P. W. F., Lipinska I., Corey D., Massaro J. M., Sutherland P., Vita J. A., Benjamin E. J., Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 3 434 439 2-s2.0-0037342568 10.1161/01.ATV.0000058402.34138.11 (Pubitemid 36337219)
108. Bondia-Pons I., Ryan L., Martinez J. A., Oxidative stress and inflammation interactions in human obesity. Journal of Physiology and Biochemistry 2012 68 4 701 711 2-s2.0-84856999269 10.1007/s13105-012-0154-2
109. Skalicky J., Muzakova V., Kandar R., Meloun M., Rousar T., Palicka V., Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clinical Chemistry and Laboratory Medicine 2008 46 4 499 505 2-s2.0-44949249095 10.1515/CCLM.2008.096 (Pubitemid 351820355)
110. Sankhla M., Sharma T. K., Mathur K., Rathor J. S., Butolia V., Gadhok A. K., Vardey S. K., Sinha M., Kaushik G. G., Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome. Clinical Laboratory 2012 58 385 392
111. Findeisen H. M., Pearson K. J., Gizard F., Zhao Y., Qing H., Jones K. L., Cohn D., Heywood E. B., de Cabo R., Bruemmer D., Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis. PLoS One 2011 6 4 2-s2.0-79954996879 10.1371/journal.pone.0018532 e18532
112. Zamboni M., Di Francesco V., Garbin U., Fratta Pasini A., Mazzali G., Stranieri C., Zoico E., Fantin F., Bosello O., Cominacini L., Adiponectin gene expression and adipocyte NF- B transcriptional activity in elderly overweight and obese women: inter-relationships with fat distribution, hs-CRP, leptin and insulin resistance. International Journal of Obesity 2007 31 7 1104 1109 2-s2.0-34250821687 10.1038/sj.ijo.0803563 (Pubitemid 46987770)
113. Mracek T., Ding Q., Tzanavari T., Kos K., Pinkney J., Wilding J., Trayhurn P., Bing C., The adipokine zinc- 2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity. Clinical Endocrinology 2010 72 3 334 341 2-s2.0-76649083327 10.1111/j.1365-2265.2009.03658.x
114. Gong F.-Y., Zhang S.-J., Deng J.-Y., Zhu H.-J., Pan H., Li N.-S., Shi Y.-F., Zinc- 2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. International Journal of Obesity 2009 33 9 1023 1030 2-s2.0-70349104688 10.1038/ijo.2009.141
115. Zappalà G., Rechler M. M., IGFBP-3, hypoxia and TNF- inhibit adiponectin transcription. Biochemical and Biophysical Research Communications 2009 382 4 785 789 2-s2.0-64549164501 10.1016/j.bbrc.2009.03.112
116. Chandrasekar B., Patel D. N., Mummidi S., Kim J. W., Clark R. A., Valente A. J., Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving erk1/2-dependent NFATc4
117. Simons P. J., van den Pangaart P. S., Aerts J. M. F. G., Boon L., Pro-inflammatory delipidizing cytokines reduces adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. Journal of Endocrinology 2007 192 2 289 299 2-s2.0-33947416692 10.1677/JOE-06-0047 (Pubitemid 46444430)
118. Gupta S., Gupta B. M. M., Metabolic syndrome: diabetes and cardiovascular disease. Indian Heart Journal 2006 58 2 149 152 2-s2.0-33749549666 (Pubitemid 44533124)
119. Mujica V., Urzúa A., Leiva E., Díaz N., Moore-Carrasco R., Vásquez M., Rojas E., Icaza G., Toro C., Orrego R., Palomo I., Intervention with education and exercise reverses the metabolic syndrome in adults. Journal of the American Society of Hypertension 2010 4 3 148 153 2-s2.0-77954731531 10.1016/j.jash.2010.02.008
120. Klimcakova E., Roussel B., Kovacova Z., Kovacikova M., Siklova-Vitkova M., Combes M., Hejnova J., Decaunes P., Maoret J. J., Vedral T., Viguerie N., Bourlier V., Bouloumié A., Stich V., Langin D., Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat. Diabetologia 2011 54 4 876 887 2-s2.0-79953826690 10.1007/s00125-010-2014-3
121. Bernal-Lopez M. R., Garrido-Sanchez L., Gomez-Carrillo V., Gallego-Perales J. L., Llorente-Cortes V., Calleja F., Gomez-Huelgas R., Badimon L., Tinahones F. J., Antioxidized LDL antibodies are associated with different metabolic pathways in patients with atherosclerotic plaque and type 2 diabetes. Diabetes Care 2012 36 4 1006 1011 10.2337/dc12-1030
122. Kallio P., Kolehmainen M., Laaksonen D. E., Kekäläinen J., Salopuro T., Sivenius K., Pulkkinen L., Mykkänen H. M., Niskanen L., Uusitupa M., Poutanen K. S., Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study. American Journal of Clinical Nutrition 2007 85 5 1417 1427 2-s2.0-34248344217 (Pubitemid 46740487)
123. Vernochet C., Peres S. B., Davis K. E., McDonald M. E., Qiang L., Wang H., Scherer P. E., Farmer S. R., C/EBP and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor γ agonists. Molecular and Cellular Biology 2009 29 17 4714 4728 2-s2.0-68849107400 10.1128/MCB.01899-08
124. Xue B., Sukumaran S., Nie J., Jusko W. J., DuBois D. C., Almon R. R., Adipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki rats. PLoS One 2011 6 2 2-s2.0-79952130515 10.1371/journal.pone.0017386 e17386
125. Jay M. A., Ren J., Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Current Diabetes Reviews 2007 3 1 33 39 2-s2.0-34247155688 10.2174/157339907779802067 (Pubitemid 46592792)
126. Van Dijk S. J., Feskens E. J. M., Bos M. B., Hoelen D. W. M., Heijligenberg R., Bromhaar M. G., De Groot L. C. P. G. M., De Vries J. H. M., Müller M., Afman L. A., A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. American Journal of Clinical Nutrition 2009 90 6 1656 1664 2-s2.0-72749100942 10.3945/ajcn.2009.27792
127. Tsuchida A., Yamauchi T., Takekawa S., Hada Y., Ito Y., Maki T., Kadowaki T., Peroxisome proliferator-activated receptor (PPAR) activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPAR PPAR γ and their combination. Diabetes 2005 54 12 3358 3370 2-s2.0-33644664433 10.2337/diabetes.54.12.3358 (Pubitemid 43334324)
128. Lowell B. B., PPAR γ: an essential regulator of adipogenesis and modulator of fat cell function. Cell 1999 99 3 239 242 2-s2.0-0033615353 10.1016/S0092-8674(00)81654-2 (Pubitemid 29519902)
129. Sugii S., Evans R. M., Epigenetic codes of PPAR γ in metabolic disease. FEBS Letters 2011 585 13 2121 2128 2-s2.0-79959824776 10.1016/j.febslet.2011.05.007
130. Heikkinen S., Auwerx J., Argmann C. A., PPAR γ in human and mouse physiology. Biochimica et Biophysica Acta 2007 1771 8 999 1013 2-s2.0-34547565190 10.1016/j.bbalip.2007.03.006 (Pubitemid 47198545)
131. Fujiki K., Kano F., Shiota K., Murata M., Expression of the peroxisome proliferator activated receptor γ gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biology 2009 7 article 38 2-s2.0-68249139820 10.1186/1741-7007-7-38
132. Luconi M., Cantini G., Serio M., Peroxisome proliferator-activated receptor gamma (PPAR γ): is the genomic activity the only answer? Steroids 2010 75 8-9 585 594 2-s2.0-77954244708 10.1016/j.steroids.2009.10.012
133. Odegaard J. I., Ricardo-Gonzalez R. R., Goforth M. H., Morel C. R., Subramanian V., Mukundan L., Eagle A. R., Vats D., Brombacher F., Ferrante A. W., Chawla A., Macrophage-specific PPAR γ controls alternative activation and improves insulin resistance. Nature 2007 447 7148 1116 1120 2-s2.0-34347354309 10.1038/nature05894 (Pubitemid 47014427)
134. Bouhlel M. A., Derudas B., Rigamonti E., Dièvart R., Brozek J., Haulon S., Zawadzki C., Jude B., Torpier G., Marx N., Staels B., Chinetti-Gbaguidi G., PPAR γ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metabolism 2007 6 2 137 143 2-s2.0-34547492488 10.1016/j.cmet.2007.06.010 (Pubitemid 47189091)
135. Odegaard J. I., Ricardo-Gonzalez R. R., Red Eagle A., Vats D., Morel C. R., Goforth M. H., Subramanian V., Mukundan L., Ferrante A. W., Chawla A., Alternative M2 activation of Kupffer cells by PPAR δ ameliorates obesity-induced insulin resistance. Cell Metabolism 2008 7 6 496 507 2-s2.0-44349161098 10.1016/j.cmet.2008.04.003 (Pubitemid 351729205)
136. Kawashima Y., Chen J., Sun H., Lann D., Hajjar R. J., Yakar S., LeRoith D., Apolipoprotein e deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus. Diabetologia 2009 52 7 1434 1441 2-s2.0-67349280145 10.1007/s00125-009-1378-8
137. Tangirala R. K., Praticó D., FitzGerald G. A., Chun S., Tsukamoto K., Maugeais C., Usher D. C., Puré E., Rader D. J., Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. Journal of Biological Chemistry 2001 276 1 261 266 2-s2.0-0035808311 10.1074/jbc.M003324200 (Pubitemid 32050315)
138. Ruan H., Miles P. D., Ladd C. M., Ross K., Golub T. R., Olefsky J. M., Lodish H. F., Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance. Diabetes 2002 51 11 3176 3188 (Pubitemid 35246963)
139. Yue L., Rasouli N., Ranganathan G., Kern P. A., Mazzone T., Divergent effects of peroxisome proliferator-activated receptor γ agonists and tumor necrosis factor on adipocyte ApoE expression. Journal of Biological Chemistry 2004 279 46 47626 47632 2-s2.0-9144242586 10.1074/jbc.M408461200 (Pubitemid 39540908)
140. Yue L., Mazzone T., Peroxisome proliferator-activated receptor γ stimulation of adipocyte ApoE gene transcription mediated by the liver receptor X pathway. Journal of Biological Chemistry 2009 284 16 10453 10461 2-s2.0-67449107799 10.1074/jbc.M808482200
141. Yue L., Christman J. W., Mazzone T., Tumor necrosis factor- -mediated suppression of adipocyte apolipoprotein E gene transcription: primary role for the nuclear factor (NF)- B pathway and NF B p50. Endocrinology 2008 149 8 4051 4058 2-s2.0-47949123626 10.1210/en.2008-0340
142. Ketsawatsomkron P., Pelham C. J., Groh S., Keen H. L., Faraci F. M., Sigmund C. D., Does peroxisome proliferator-activated receptor- γ (PPAR γ) protect from hypertension directly through effects in the vasculature? Journal of Biological Chemistry 2010 285 13 9311 9316 2-s2.0-77951221502 10.1074/jbc.R109.025031
143. Halabi C. M., Beyer A. M., de Lange W. J., Keen H. L., Baumbach G. L., Faraci F. M., Sigmund C. D., Interference with PPAR γ function in smooth muscle causes vascular dysfunction and hypertension. Cell Metabolism 2008 7 3 215 226 2-s2.0-39649100393 10.1016/j.cmet.2007.12.008 (Pubitemid 351285526)
144. Guri A. J., Hontecillas R., Ferrer G., Casagran O., Wankhade U., Noble A. M., Eizirik D. L., Ortis F., Cnop M., Liu D., Si H., Bassaganya-Riera J., Loss of PPAR γ in immune cells impairs the ability of abscisic acid to improve insulin sensitivity by suppressing monocyte chemoattractant protein-1 expression and macrophage infiltration into white adipose tissue. Journal of Nutritional Biochemistry 2008 19 4 216 228 2-s2.0-39749200215 10.1016/j.jnutbio.2007.02.010 (Pubitemid 351312272)
145. Ramji D. P., Foka P., CCAAT/enhancer-binding proteins: structure, function and regulation. Biochemical Journal 2002 365 3 561 575 2-s2.0-0036683653 10.1042/BJ20020508 (Pubitemid 34864439)
146. Chatterjee R., Bhattacharya P., Gavrilova O., Glass K., Moitra J., Myakishev M., Pack S., Jou W., Feigenbaum L., Eckhaus M., Vinson C., Suppression of the C/EBP family of transcription factors in adipose tissue causes lipodystrophy. Journal of Molecular Endocrinology 2011 46 3 175 192 2-s2.0-79959529886 10.1530/JME-10-0172
147. Park S.-K., Oh S.-Y., Lee M.-Y., Yoon S., Kim K.-S., Kim J.-W., CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 2004 53 11 2757 2766 2-s2.0-7044234994 10.2337/diabetes.53.11.2757 (Pubitemid 39425900)
148. Koshiishi C., Park H.-M., Uchiyama H., Tanaka Y., Regulation of expression of the mouse adiponectin gene by the C/EBP family via a novel enhancer region. Gene 2008 424 1-2 141 146 2-s2.0-52949137872 10.1016/j.gene.2008.07.039
149. Kita A., Yamasaki H., Kuwahara H., Moriuchi A., Fukushima K., Kobayashi M., Fukushima T., Takahashi R., Abiru N., Uotani S., Kawasaki E., Eguchi K., Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein- β and tumor necrosis factor- Biochemical and Biophysical Research Communications 2005 331 2 484 490 2-s2.0-20944443083 10.1016/j.bbrc.2005.03.205 (Pubitemid 40602663)
150. Qiao L., Shao J., SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer- binding protein transcriptional complex. Journal of Biological Chemistry 2006 281 52 39915 39924 2-s2.0-33845985335 10.1074/jbc.M607215200 (Pubitemid 46041795)
151. Qiao L., MacLean P. S., Schaack J., Orlicky D. J., Darimont C., Pagliassotti M., Friedman J. E., Shao J., C/EBP regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 2005 54 6 1744 1754 2-s2.0-20044372908 10.2337/diabetes.54.6.1744 (Pubitemid 40770764)
152. Bennett C. E., Nsengimana J., Bostock J. A., Cymbalista C., Futers T. S., Knight B. L., McCormack L. J., Prasad U. K., Riches K., Rolton D., Scarrott T., Barrett J. H., Carter A. M., CCAAT/enhancer binding protein β and δ gene variants: associations with obesity related phenotypes in the Leeds Family Study. Diabetes and Vascular Disease Research 2010 7 3 195 203 2-s2.0-79551698074 10.1177/1479164110366274
153. Sekine O., Nishio Y., Egawa K., Nakamura T., Maegawa H., Kashiwagi A., Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Journal of Biological Chemistry 2002 277 39 36631 36639 2-s2.0-0037184101 10.1074/jbc.M206266200
154. Sato Y., Nishio Y., Sekine O., Kodama K., Nagai Y., Nakamura T., Maegawa H., Kashiwagi A., Increased expression of CCAAT/enhancer binding protein-beta and -delta and monocyte chemoattractant protein-1 genes in aortas from hyperinsulinaemic rats. Diabetologia 2007 50 2 481 489 2-s2.0-34047112370 10.1007/s00125-006-0480-4
155. Pope R. M., Leutz A., Ness S. A., C/EBP β regulation of the tumor necrosis factor gene. Journal of Clinical Investigation 1994 94 4 1449 1455 2-s2.0-0028170158
156. He Z., Jiang T., Wang Z., Levi M., Li J., Modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue. American Journal of Physiology 2004 287 3 E424 E430 2-s2.0-4143116652 10.1152/ajpendo.00568.2003 (Pubitemid 39095875)
157. Herman M. A., Peroni O. D., Villoria J., Schön M. R., Abumrad N. A., Blüher M., Klein S., Kahn B. B., A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 2012 484 7394 333 338 2-s2.0-84859921736 10.1038/nature10986
158. Im S.-S., Kwon S.-K., Kang S.-Y., Kim T.-H., Kim H.-I., Hur M.-W., Kim K.-S., Ahn Y.-H., Regulation of GLUT4 gene expression by SREBP-1c in adipocytes. Biochemical Journal 2006 399 1 131 139 2-s2.0-33749375790 10.1042/BJ20060696 (Pubitemid 44505414)